Melatonin: What It Actually Does and Why ARC Works Differently

Melatonin is arguably one of the most widely recognised sleep supplement across Europe, and it seems intuitive that a sleep and recovery formula would include it.

The decision not to include melatonin was deliberate, and I think it is worth explaining the reasoning in some detail. Not because melatonin is without value, but because I believe there are important things people are not always told about it, and because ARC takes a fundamentally different approach that I think is worth understanding.

What Melatonin Does and Does Not Do

Melatonin is a hormone produced by the pineal gland in response to darkness. Its primary role is to signal to the body that the light to dark transition has occurred, enabling the downstream physiological shifts that make sleep possible: a drop in core temperature, a reduction in heart rate, and the gradual quieting of neural activity. It is a timing signal, not a sedative.

Used appropriately, exogenous melatonin has a well supported evidence base for specific situations. Jet lag, shift work, and delayed sleep phase disorder are the clearest examples. These are circumstances where the body's internal clock has been shifted out of alignment with the external light cycle, and melatonin supplementation provides a useful cue to help reanchor it. For these purposes, it works.

But the way melatonin is marketed and used in the general population is often quite different from these specific, time limited applications. And that gap is where I think it is worth pausing.

The Concerns With Consistent, Long Term Melatonin Use

This is an area where the science calls for some caution, even though the conversation in the wellness space rarely reflects that.

The first concern is feedback inhibition. The body is constantly monitoring the hormones it produces and adjusting its own output accordingly. When exogenous melatonin is introduced regularly, particularly at the relatively high doses commonly found in consumer products (often 5mg or 10mg, which is several times physiological levels), there is evidence that the pineal gland may reduce its own endogenous production in response. The body, in effect, begins to rely on the external source rather than maintaining its own synthesis. How pronounced this effect is varies between individuals and remains an active area of research, but it is a pharmacologically plausible and observed phenomenon that warrants consideration.

The concern is not that melatonin is harmful in the short term. It is that consistently supplementing a hormone your body produces naturally may, over time, reduce your body's motivation to produce it adequately on its own.

The second concern relates to dose. Most melatonin products sold in europe are significantly over dosed relative to what the evidence suggests is physiologically appropriate. Research indicates that doses in the range of 0.3mg to 1mg are sufficient to produce the circadian signalling effect melatonin is intended to provide. Products containing 5mg or 10mg are not delivering five or ten times the benefit. They are delivering a pharmacological dose of a hormone your body is designed to produce at much lower concentrations. The effects of sustained supraphysiological melatonin exposure on endocrine feedback, receptor sensitivity, and circadian entrainment over years of use are not fully characterised.

The third concern is perhaps the most practical: melatonin supplementation, even when it works, does not address why sleep is disrupted. If the underlying issue is elevated evening cortisol, nutritional deficiency, or insufficient GABAergic tone, taking melatonin may improve symptoms temporarily while the root cause continues unchecked. When supplementation stops, the problem remains exactly where it was.

Why Addressing the Pathway Matters More

For most people who struggle with sleep quality, the issue is not that the pineal gland has stopped producing melatonin. It is that something is interfering with the system that enables melatonin to rise, be effective, and do its job.

Cortisol is the most significant of those interferences. Melatonin and cortisol are physiologically antagonistic: high cortisol in the evening directly suppresses melatonin signalling, regardless of how much the pineal gland is producing. This is the most common mechanism behind the wired but tired experience, where the body is fatigued but the nervous system remains alert and resistant to sleep.

Magnesium deficiency is another frequently overlooked factor. Magnesium is a required cofactor in melatonin synthesis, and insufficiency, which is common in the UK adult population, directly impairs the body's ability to produce adequate melatonin. Similarly, vitamin B6 in its active form is required for the conversion of tryptophan to serotonin, which is itself the precursor to melatonin. When these cofactors are insufficient, the synthesis pathway is limited regardless of pineal gland function.

Finally, the GABAergic environment matters. Even when melatonin is produced at appropriate levels, it cannot do its job effectively if the nervous system is in a state of heightened arousal. GABA is the primary inhibitory neurotransmitter responsible for quieting neural activity and enabling the transition into sleep. Low GABAergic tone, which is common in chronically stressed individuals, means melatonin is signalling into a system that is not ready to receive it.

What ARC Does Instead

ARC was designed to address these upstream factors rather than supplement the output of a system that remains disrupted.

Ashwagandha (7% withanolides, 300mg) targets cortisol via HPA axis modulation. In a 60 day double blind placebo controlled trial, this standardised extract was associated with a 23% reduction in morning serum cortisol compared to placebo. Restoring a healthy evening cortisol decline is, in my view, the single most important thing you can do to improve the conditions for natural melatonin production.

Magnesium bisglycinate (providing 148mg of elemental magnesium) addresses one of the most common nutritional deficiencies implicated in impaired melatonin synthesis, using a highly bioavailable form that is meaningfully absorbed rather than simply excreted.

P5P at 2.5mg provides the active B6 cofactor required for serotonin synthesis. Supporting this step in the tryptophan to serotonin to melatonin pathway means the body has the biochemical building blocks it needs to produce melatonin naturally and in appropriate amounts.

L theanine (200mg active from a 40% standardised extract) and apigenin (50mg) support GABAergic tone and alpha wave brain activity, creating the neurological conditions that allow melatonin to be effective once it is produced.

The goal of ARC is not to replace what your body does. It is to restore the conditions under which your body can do it properly.

A Note on Individual Circumstances

I want to be clear that I am not suggesting melatonin supplementation is never appropriate. For jet lag, shift work, or clinically identified circadian rhythm disorders, there are good reasons to use it under appropriate guidance under the guidance of a licensed practitioner. For instance, when I used to practice as a pharmacist in the UK, melatonin was only available only on prescription precisely because it is recognised as a pharmacologically active hormone, and that regulatory context is worth being aware of.

What I am suggesting is that for the majority of people using melatonin as a general sleep supplement, night after night, the more useful question is what is disrupting sleep in the first place. ARC was formulated around that question.

If your sleep is poor because your body is struggling to produce or respond to melatonin naturally, the most durable solution is to understand why that is happening and to address it at that level. That is what ARC is designed to support.